Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Detecting Opsoclonus-myoclonus-ataxia syndrome (OMAS): associations of novel eye tracking metrics with structural localizations in the midbrain
EF 2021-22
Résumé
Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare but serious inflammatory neurological disorder that typically affects young children and greatly disturbs their quality of life. There are well-established immunotherapies that have shown to be highly effective if administered early. However, since there are no current established diagnostic tests, delayed diagnosis in children with OMAS is common and leads to poorer long-term outcomes. The need for early diagnosis and intervention in OMAS is a critical gap that must be addressed as it can greatly change the developmental trajectory of this disorder in children. Thus, our research intends to examine if eye-tracking can address this knowledge gap. Eye-tracking is a non-invasive and well-tolerated test that has displayed eye tracking abnormalities in patients with neurological disorders. Unfortunately, previous eye tracking methods have been inaccessible to younger children due to the need for sustained attention and cooperation. Our study will use a novel technique of free viewing to assess eye tracking signatures in young children with OMAS. Based on our preliminary data with this novel technique, OMAS children demonstrate a distinctive eye tracking pattern that may point to functional abnormalities localized in the superior colliculus (SC) of the midbrain. Our study will further examine this association by evaluating eye-tracking metrics in children with OMAS compared to age and sex matched healthy control children. Results from this study will elude to a distinctive disease signature in OMAS to improve disease outcomes, and open the door to greater understanding of disease signatures in children with other neurological conditions by using this novel free-viewing task.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466995
Name
Wu Susana
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Detecting Opsoclonus-myoclonus-ataxia syndrome (OMAS): associations of novel eye tracking metrics with structural localizations in the midbrain
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmune; Disease Specific Biomarker; Eye-Tracking; Free Viewing; Midbrain; Neurological; Novel; Opsoclonus-Myoclonus-Ataxia Syndrome (Omas); Structural Localizations; Superior Colliculus
Abstract
Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare but serious inflammatory neurological disorder that typically affects young children and greatly disturbs their quality of life. There are well-established immunotherapies that have shown to be highly effective if administered early. However, since there are no current established diagnostic tests, delayed diagnosis in children with OMAS is common and leads to poorer long-term outcomes. The need for early diagnosis and intervention in OMAS is a critical gap that must be addressed as it can greatly change the developmental trajectory of this disorder in children. Thus, our research intends to examine if eye-tracking can address this knowledge gap. Eye-tracking is a non-invasive and well-tolerated test that has displayed eye tracking abnormalities in patients with neurological disorders. Unfortunately, previous eye tracking methods have been inaccessible to younger children due to the need for sustained attention and cooperation. Our study will use a novel technique of free viewing to assess eye tracking signatures in young children with OMAS. Based on our preliminary data with this novel technique, OMAS children demonstrate a distinctive eye tracking pattern that may point to functional abnormalities localized in the superior colliculus (SC) of the midbrain. Our study will further examine this association by evaluating eye-tracking metrics in children with OMAS compared to age and sex matched healthy control children. Results from this study will elude to a distinctive disease signature in OMAS to improve disease outcomes, and open the door to greater understanding of disease signatures in children with other neurological conditions by using this novel free-viewing task.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wu, Susana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~